FDA 510(k) · Wellue / Viatom

K150869: Checkme Pro Health Monitor (Viatom Technology Co., Ltd.)

Viatom Technology Co., Ltd. received FDA 510(k) K150869 for Checkme Pro Health Monitor, with a decision date of Dec 10, 2015 (substantially equivalent).

Prescription or OTC: Unknown (no FDA document we parsed states it).

FDA record for K150869FDA summary or statement (PDF)

FDA facts

Official fields for K150869
FDA numberK150869
Pathway510(k)
ApplicantViatom Technology Co., Ltd.
Device nameCheckme Pro Health Monitor
Product codeMWI: Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms)
Regulation (21 CFR)870.2300
Device classClass 2
Date receivedApr 1, 2015
Decision dateDec 10, 2015
DecisionSubstantially Equivalent (SESE)
510(k) typeTraditional

Source: openFDA device 510(k) data, data through Oct 26, 2026.

Indications for use parsed from FDA documents

The Checkme Pro Health Monitor is intended to be used for measuring, displaying, reviewing and storing of ECG (adults only), oxygen saturation and pulse rate (adults only for continuous data collection and recording, adults and pediatrics for spot checking) and temperature in the home or in healthcare facilities. This device is not intended to substitute for a hospital diagnostic ECG device and also not to be used on patients with implanted cardiac devices, such as pacemakers and/or implanted cardio-defibrillators (ICDs).

Extracted automatically from FDA's 510(k) summary. It can contain extraction errors and is not a verified quote. Read the wording in the FDA PDF before relying on it.

Predicates parsed from FDA documents

FDA numbers found next to the word "predicate" in the summary. The list can include reference devices; check the PDF for which device is the primary predicate.

Later records that cite K150869

  • K203812 Oxyfit Pulse Oximeter (Wellue / Viatom, Nov 8, 2022, DQA)
  • K191088 Checkme O2 Pulse Oximeter (Wellue / Viatom, Dec 2, 2019, DQA)

ChatPPG interpretation

A 510(k) decision of "substantially equivalent" means FDA found the device as safe and effective as a legally marketed predicate. FDA's word for this is cleared, not approved. The clearance covers the device and indications in this submission; it does not extend to other features or versions of the same product that were not part of it. See FDA cleared vs approved.

Product code MWI is "Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms)", class 2, 21 CFR 870.2300.

Our labels for filtering: claim Remote / vital-sign monitoring, sensor Unknown. These are heuristics, not FDA fields.